Home/Filings/4/0001493152-22-032631
4//SEC Filing

Howe Jill Ann 4

Accession 0001493152-22-032631

CIK 0000876343other

Filed

Nov 15, 7:00 PM ET

Accepted

Nov 16, 4:17 PM ET

Size

5.6 KB

Accession

0001493152-22-032631

Insider Transaction Report

Form 4
Period: 2022-11-14
Howe Jill Ann
Chief Financial Officer
Transactions
  • Award

    Employee Stock Option (right to buy)

    2022-11-14+1,000,0001,000,000 total
    Exercise: $1.36Exp: 2032-11-14Common Shares (1,000,000 underlying)
Footnotes (1)
  • [F1]This option will vest as to one quarter of the shares subject to the option on November 14, 2023, and the balance will vest in 36 successive substantially equal installments thereafter, subject to the reporting person's continuous employment.

Documents

1 file

Issuer

Lineage Cell Therapeutics, Inc.

CIK 0000876343

Entity typeother

Related Parties

1
  • filerCIK 0001892397

Filing Metadata

Form type
4
Filed
Nov 15, 7:00 PM ET
Accepted
Nov 16, 4:17 PM ET
Size
5.6 KB